Lynette Newby

Lynette Newby serves as a key procurement professional within Naval Medical Research Center – Guam (NMRTC Guam), supporting the Department of the Navy’s mission to sustain operational medical readiness across the Indo-Pacific region. She manages the acquisition of critical in-vitro diagnostic substances and specialized healthcare supplies essential for deploying life-saving diagnostic capabilities in austere and expeditionary environments. Her work directly enables the delivery of acute care, point-of-care testing, and clinical surveillance functions aboard ships, forward operating bases, and partner nation facilities. She handles complex, high-stakes procurements governed by Federal Acquisition Regulation (FAR) Part 35 and Defense Federal Acquisition Regulation Supplement (DFARS) requirements, ensuring compliance with stringent quality and traceability standards for medical diagnostics. While specific contractor names are not publicly disclosed, Newby maintains a consistent working relationship with manufacturers and distributors of clinical diagnostic reagents, assay kits, and laboratory consumables certified under ISO 13485 and FDA regulations. Her procurement approach emphasizes technical validation, supply chain resilience, and regulatory compliance, fostering long-term vendor partnerships with firms capable of meeting the unique demands of military medical logistics in remote theaters. Newby demonstrates a strong commitment to small business participation, with approximately one-third of her acquisitions structured as total small business set-asides under FAR 19.5. Her contracting patterns reflect a deliberate effort to engage qualified small businesses in the diagnostic manufacturing space, aligning with DoD’s socioeconomic goals without relying on specialized set-asides such as 8(a) or HUBZone. Her portfolio prioritizes competitive, open small business opportunities that ensure innovation and agility in medical supply chains. Her technical focus is exclusively centered on NAICS 325413—in-vitro diagnostic substance manufacturing—encompassing molecular assays, immunoassays, microbiological culture media, and diagnostic kits used in field laboratories and shipboard medical units. She possesses deep expertise in the regulatory and technical specifications governing diagnostic product performance, stability, and biohazard compliance, ensuring procurement decisions align with military medical operational requirements.